Our cancer genetics group in the Human Oncology and Pathogenesis Program at Memorial Sloan Kettering focuses on under-studied, poor prognosis cancers of the head and neck. We use multi-dimensional genomic analyses, coupled with correlative molecular and clinical investigation, to study the genetic drivers of these tumors. My main interest is the application of genomic discovery data to generate new hypotheses and answer clinical questions.